Oppenheimer & Co. Newsletter
-
Visa's Q1 Is A Positive Teaser Ahead Of Investor Day: Analyst
31 Jan 2025 21:53 GMT
… heading into its February 20th Investor Day.
Goldman Sachs: … strategy and the upcoming Investor Day.
The analyst remains … patterns and easing headwinds.
Oppenheimer: Per the analyst, Visa … Benzinga does not provide investment advice. All rights reserved.
-
Oppenheimer: Q4 Earnings Snapshot
31 Jan 2025 17:38 GMT
… YORK (AP) — NEW YORK (AP) — Oppenheimer Holdings Inc. (OPY) on Friday … 92 cents per share.
The investment banking and broker-dealer services … ;ap) using data from Zacks Investment Research. Access a Zacks stock …
-
SAB BIO to Participate in Upcoming Investor Conferences
31 Jan 2025 12:00 GMT
… participate in the following investor conferences: Event: Guggenheim … sabs/1999239 Event: Oppenheimer 35th Annual Healthcare Life … relied on, by any investor as a guarantee, prediction … Communications
khollon@sab.bio Investor Relations:
Kevin Gardner
…
-
Mount Logan Capital Inc. Completes Strategic Minority Investment in Runway Growth Capital LLC
31 Jan 2025 02:20 GMT
… its previously announced minority investment in Runway Growth Capital … legal counsel to BC Partners. Oppenheimer & Co. Inc. … LLC is the investment adviser to investment funds, including Runway … addition, the number of investors in the United States, …
-
Mount Logan Capital Inc. Completes Strategic Minority Investment in Runway Growth Capital LLC
31 Jan 2025 01:35 GMT
… its previously announced minority investment in Runway Growth Capital … legal counsel to BC Partners. Oppenheimer & Co. Inc. … LLC is the investment adviser to investment funds, including Runway … addition, the number of investors in the United States, …
-
Tarsus to Participate in Upcoming Investor Conferences
30 Jan 2025 22:00 GMT
… fireside chats at two upcoming investor conferences:
The Guggenheim SMID … a.m. ET
The Oppenheimer 35th Annual Healthcare Life Sciences … 922-0801
AKemp@tarsusrx.com Investor Contact:
David Nakasone
Head … of Investor Relations
(949) 620-3223 …
-
Trevi Therapeutics To Participate In Upcoming February Investor Conferences
30 Jan 2025 13:27 GMT
… financial Officer
Oppenheimer Healthcare 2025 Winter CEO & Investor Summit
February … Jennifer Good, President and CEO
Oppenheimer 35th Annual Healthcare Life Sciences … (formerly Twitter) and LinkedIn .
Investor Contact
Jonathan Carlson
Trevi Therapeutics …
-
UroGen Pharma to Present at Upcoming Investor Conferences
30 Jan 2025 13:13 GMT
… will participate at the following investor conferences in February:
Guggenheim Securities … 1x1 investor meetings
Location:
New York, NY
Webcast Link:
here
Oppenheimer 35th … ET
Format:
Presentation and 1x1 investor meetings
Location:
Virtual
Webcast …
-
PolyPid to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
30 Jan 2025 12:00 GMT
… will present at the Oppenheimer 35th Annual Healthcare … on-one investor meetings during this event. Investors interested in … conference should contact their Oppenheimer representative. About PolyPid PolyPid … 5995
IR@Polypid.com Investors:
Brian Ritchie
LifeSci …
-
Kymera Therapeutics to Participate in Upcoming February Investor Conferences
30 Jan 2025 12:00 GMT
… at the following upcoming investor events:
Guggenheim SMID Cap … a.m. ET; and
Oppenheimer 35th Annual Healthcare Life … on X or LinkedIn. Investor and Media Contact: Justine … Koenigsberg
Vice President, Investor Relations
investors@kymeratx.com
media@kymeratx …